Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 24;10(1):33-8.
doi: 10.5114/aoms.2013.38708. Epub 2013 Oct 31.

Quality of life (QOL) evaluation after acute coronary syndrome with simultaneous clopidogrel treatment

Jerzy Chudek  1 , Adam Kowalczyk  2 , Anna Krystyna Kowalczyk  3 , Joanna Kwiatkowska  4 , Grzegorz Raczak  2 , Dariusz Kozłowski  5
Affiliations

Quality of life (QOL) evaluation after acute coronary syndrome with simultaneous clopidogrel treatment

Jerzy Chudek et al. Arch Med Sci. .

Abstract

Introduction: Double antiplatelet therapy with clopidogrel and acetylsalicylic acid is a standard procedure after acute coronary syndrome. This treatment carries a higher risk of complications. The main goal of this research was to assess the patients' quality of life after undergoing antiplatelet therapy with clopidogrel after acute coronary syndrome (ACS).

Material and methods: In the questionnaire research 3220 patients after ACS and treated with clopidogrel were included. The evaluation was carried out with the quality of life questionnaire SF-12.

Results: 37.9% of the interviewees experienced ACS-ST-elevation myocardial infarction (STEMI), 62.1% non-ST-elevation myocardial Infarction (NSTEMI), on average within 23 ±42 weeks (p < 0.05). 7.2% of the interviewees were receiving non-invasive treatment and in 2.4% cases it was fibrinolysis. 90.4% were treated with primary angioplasty and stenting. In 53.8% of cases a covered stent (DES) was implanted. 95.6% of the patients received, besides clopidogrel, acetylsalicylic acid. The lowest quality of life was observed after non-invasive treatment or fibrinolytic only (p < 0.05). The quality of life in those patients who underwent angioplasty and stent implantation was similar (p < 0.05). With time, a progressive improvement of all assessed quality of life aspects was observed (p < 0.05). The improvement was noted regardless of the ACS treatment method (p < 0.001). The differences between the patients were smaller at each successive evaluation (p < 0.05). In the case of vitality, emotional and psychic condition, they disappeared completely (p < 0.05).

Conclusions: The quality of life rises along with time passed after acute coronary syndrome. Invasive methods provide better quality of life than fibrinolysis and non-invasive treatment in the acute coronary syndrome patients.

Keywords: acute coronary syndrome; clopidogrel; coronary angioplasty; fibrinolysis; quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quality of life comparison between males and females after acute coronary syndrome assessed during the first visit *p < 0.001
See this image and copyright information in PMC

References

    1. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598–660. - PubMed
    1. Svilaas T, van der Horst IC, Zijlstra F. A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with acute myocardial infarction: angiographic measures in relation to clinical outcome. Heart. 2007;93:792–800. - PMC - PubMed
    1. Brar SS, Leon MB, Stone GW, et al. Use of drug-eluting stents in acute myocardial infarction: a systematic review and metaanalysis. J Am Coll Cardiol. 2009;53:1677–89. - PubMed
    1. Lee SW, Park SW, Hong MK, et al. Triple versus dual antiplatelet therapy after coronary stenting – impact on stent thrombosis. J Am Coll Cardiol. 2005;46:1833–7. - PubMed
    1. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–78. - PubMed

LinkOut - more resources